Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.

Ibrahim SF, Ahronowitz I, McCalmont TH, Hernandez Pampaloni M, Ryan JL, Yu SS.

Dermatol Surg. 2013 Sep;39(9):1323-33. doi: 10.1111/dsu.12246. Epub 2013 Jun 18.

PMID:
23777452
2.

The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.

Concannon R, Larcos GS, Veness M.

J Am Acad Dermatol. 2010 Jan;62(1):76-84. doi: 10.1016/j.jaad.2009.06.021.

PMID:
20082888
3.

The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.

George A, Girault S, Testard A, Delva R, Soulié P, Couturier OF, Morel O.

Nucl Med Commun. 2014 Mar;35(3):282-90. doi: 10.1097/MNM.0000000000000039.

PMID:
24240193
4.

Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.

Hawryluk EB, O'Regan KN, Sheehy N, Guo Y, Dorosario A, Sakellis CG, Jacene HA, Wang LC.

J Am Acad Dermatol. 2013 Apr;68(4):592-9. doi: 10.1016/j.jaad.2012.08.042. Epub 2012 Nov 3.

PMID:
23127473
5.

18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.

Siva S, Byrne K, Seel M, Bressel M, Jacobs D, Callahan J, Laing J, Macmanus MP, Hicks RJ.

J Nucl Med. 2013 Aug;54(8):1223-9. doi: 10.2967/jnumed.112.116814. Epub 2013 Jun 10.

6.

Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.

Yao M, Smith RB, Hoffman HT, Funk GF, Graham MM, Buatti JM.

Am J Clin Oncol. 2005 Apr;28(2):205-10.

PMID:
15803018
7.

15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.

Byrne K, Siva S, Chait L, Callahan J, Bressel M, Seel M, MacManus MP, Hicks RJ.

J Nucl Med. 2015 Sep;56(9):1328-33. doi: 10.2967/jnumed.115.158261. Epub 2015 Jul 9.

8.

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?

Iagaru A, Quon A, McDougall IR, Gambhir SS.

Mol Imaging Biol. 2006 Jul-Aug;8(4):212-7.

PMID:
16724293
9.

Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.

Epstude M, Tornquist K, Riklin C, di Lenardo F, Winterhalder R, Hug U, Strobel K.

Clin Nucl Med. 2013 Apr;38(4):283-4. doi: 10.1097/RLU.0b013e318281658e.

PMID:
23429397
10.

Role of nuclear medicine in staging and management in a case of Merkel cell carcinoma.

Ochoa-Figueroa MA, Uña-Gorospe J, Allende-Riera A, Muñoz-Iglesias J, Cárdenas-Negro C, González-Delgado B.

Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec;31(6):354-6. doi: 10.1016/j.remn.2011.10.008. Epub 2011 Dec 15. English, Spanish. No abstract available.

11.

Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.

Ben-Haim S, Garkaby J, Primashvili N, Goshen E, Shapira R, Davidson T, Israel O, Epelbaum R.

Nucl Med Commun. 2016 Aug;37(8):865-73. doi: 10.1097/MNM.0000000000000523.

PMID:
27092665
12.
13.

Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.

Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S.

BJU Int. 2013 Oct;112(6):729-34. doi: 10.1111/bju.12109. Epub 2013 Jun 24.

14.

Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.

Lu Y, Fleming SE, Fields RC, Coit DG, Carrasquillo JA.

Clin Nucl Med. 2012 Aug;37(8):759-62. doi: 10.1097/RLU.0b013e31825ae8e7.

PMID:
22785503
15.

Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma.

Sollini M, Taralli S, Milella M, Erba PA, Rubagotti S, Fraternali A, Roncali M, Moscarella E, Perotti G, Rufini V, Versari A.

J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1507-11. doi: 10.1111/jdv.13405. Epub 2015 Oct 7.

PMID:
26446694
16.

PET/CT imaging of metastatic Merkel cell carcinoma to the adrenal glands.

Greene G, Mezheritskiy I, Biko DM.

BMJ Case Rep. 2010 Oct 13;2010. pii: bcr0320102788. doi: 10.1136/bcr.03.2010.2788. No abstract available.

17.

[Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].

Amal G, Sara T, Ghofrane CS, Malika AI, Majdouline H, Souha S, Abdelatif B, Najoua T, Ghita B, Zineb B, Nabil C.

Pan Afr Med J. 2016 Apr 5;23:156. doi: 10.11604/pamj.2016.23.156.8571. eCollection 2016. French.

18.

AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT.

Clapp AJ, Peller PJ, Subramaniam RM.

AJR Am J Roentgenol. 2011 Jun;196(6 Suppl):WS83-5. doi: 10.2214/AJR.10.7243. No abstract available.

PMID:
21606246
19.

18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.

Kumar R, Xiu Y, Zhuang HM, Alavi A.

Br J Dermatol. 2006 Aug;155(2):357-63.

PMID:
16882175
20.

Interest of (18)F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients.

Maury G, Dereure O, Du-Thanh A, Mariano-Goulart D, Guillot B.

J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1420-7. doi: 10.1111/j.1468-3083.2011.03994.x. Epub 2011 Mar 2.

PMID:
21366705

Supplemental Content

Support Center